Filter by Lead Doctor (All Doctors) Kim Margolin, M.D.Richard Essner, M.D. Title Physician Unresectable, or metastatic (advanced) melanoma (IO Biotech). NCT ID : 05155254 Protocol Number : IO102-IO103-013 Phase : III Location : Santa Monica, Ca Kim Margolin, M.D. A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Melanoma (Morpheus-Melanoma) NCT ID : 05116202 Protocol Number : BO43328 (Morpheus) Phase : Ib/2 Location : Santa Monica, Ca Kim Margolin, M.D. DecisionDx-Melanoma Impact on Sentinel Lymph Node Biopsy Decisions and Clinical Outcomes (DECIDE) NCT ID : N/A Protocol Number : CBI_2019_SLNBprosp_001 Phase : N/A Location : Santa Monica, CA Richard Essner, M.D. Anti-PD1 refractory/relapsed, unresectable Stage III or IV melanoma. NCT ID : 04526899 Protocol Number : BNT111-01 Phase : 2 Location : Santa Monica, CA Kim Margolin, M.D. Stage III or IV Melanoma: Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A) NCT ID : 04305041 Protocol Number : MK-3475-02A Phase : 1/2 Location : Santa Monica, CA Kim Margolin, M.D.
